TANFAC Industries Issues Postal Ballot Notice for Director Appointments via E-Voting

4 min read     Updated on 13 May 2026, 12:16 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

TANFAC Industries has issued a Postal Ballot Notice seeking shareholder approval for the appointment of Dr. L. Ravichandran as Whole-time Director (two-year term, total CTC of INR 80,00,000 per annum) and Dr. Ajay Kumar Singh as Non-Executive Independent Director (five-year term), both effective May 06, 2026. Remote e-voting via CDSL is scheduled from May 13 to June 11, 2026, with results to be announced on or before June 13, 2026.

powered bylight_fuzz_icon
39639121

*this image is generated using AI for illustrative purposes only.

TANFAC Industries Limited has issued a Postal Ballot Notice dated May 06, 2026, seeking shareholder approval for three resolutions relating to the appointment of two directors approved by its Board of Directors. The notice, disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was communicated to BSE Limited on May 12, 2026, and signed by Managing Director Afzal Malkani. The notice is being sent only through electronic mode to members whose e-mail addresses are registered as on the cut-off date of Friday, May 08, 2026.

Postal Ballot and E-Voting Schedule

The company has engaged Central Depository Services (India) Limited (CDSL) to facilitate remote e-voting for its members. The voting window and resolution details are as follows:

Parameter: Details
E-Voting Start: Wednesday, May 13, 2026 at 9:00 a.m. (IST)
E-Voting End: Thursday, June 11, 2026 at 5:00 p.m. (IST)
Cut-off Date: Friday, May 08, 2026
Scrutinizer: M.D. Baid Associates, Practicing Company Secretaries
Results Announcement: On or before June 13, 2026

The three resolutions put to members for approval are:

S.No Resolution Type
1. Appointment of Dr. Ajay Kumar Singh (DIN: 08532830) as Non-Executive Independent Director Special Resolution
2. Appointment of Dr. L. Ravichandran (DIN: 02643264) as Director Ordinary Resolution
3. Appointment of Dr. L. Ravichandran (DIN: 02643264) as Whole-time Director Ordinary Resolution

The Scrutinizer will submit the report to the Chairperson after completion of scrutiny, and results will be announced at the registered office, intimated to the stock exchange, and uploaded on the company's website and CDSL's website.

Appointment Details at a Glance

Both appointments were approved by the Board on May 06, 2026, based on the recommendations of the Nomination and Remuneration Committee. The key parameters of both appointments are as follows:

Parameter: Dr. L. Ravichandran Dr. Ajay Kumar Singh
Designation: Additional Director & Whole-time Director Additional Director – Non-Executive Independent Director
DIN: 02643264 08532830
Age: 65 years 49 years
Effective Date: May 06, 2026 May 06, 2026
Term End Date: May 05, 2028 May 05, 2031
Term Duration: Two years Five years
Relationship with other Directors: Not related to any other Director Not related to any other Director

Dr. L. Ravichandran – Whole-time Director

Dr. L. Ravichandran is a seasoned professional with over four decades of experience at TANFAC Industries, having contributed across the full spectrum of operations including Production, Maintenance, Quality, Safety, Environment, R&D, and New Product Development. He holds a Ph.D. in Chemistry and has successfully developed and commercialised several new products during his tenure. His leadership has been associated with cost-effective innovations, environmental excellence, and long-term value creation. He does not hold any other directorship or committee memberships outside TANFAC Industries.

The remuneration approved for Dr. L. Ravichandran as Whole-time Director, not exceeding 5% of net profits computed under Section 198 of the Companies Act, 2013, is detailed below:

Remuneration Component: Amount (INR Per Annum)
Basic Salary (A): 31,63,500
Special Allowance: 28,75,000
Uniform Allowance: 9,600
Education Allowance: 2,400
Medical Reimbursement: 15,000
Leave Travel Allowance: 2,63,625
Total Allowances & Reimbursements (B): 31,65,625
Car Valuation: 4,00,000
Car Operating Expense: 4,80,000
Total Car Benefits (C): 8,80,000
HRA (D): 7,90,875
Guaranteed Cash Compensation (A+B): 63,29,125
Fixed Compensation w/o Housing (A+B+C): 72,09,125
Total CTC (A+B+C+D): 80,00,000

Dr. Ajay Kumar Singh – Non-Executive Independent Director

Dr. Ajay Kumar Singh is a versatile professional with extensive experience in leadership, programme planning and design, teaching, monitoring and evaluation, business development, and consulting. He serves as the Associate Director at the Indian School of Business, Hyderabad, and is the recipient of the prestigious Rashtrapati Rover Award. His academic qualifications include a Post-Doctoral Fellowship in Social Marketing from ISB Hyderabad, a Ph.D. from Chaudhary Charan Singh University, and an MBA in Marketing from RSMT Purvanchal University. He has delivered over 1,000 days of mid-career training to organisations such as the State Bank of India, Bank of Baroda, NTPC, ONGC, IndiGo, Tata Steel, ITC, and Sun Pharma. He also serves as a member of the Academic Advisory Council of the Institute of Public Enterprise, Hyderabad, Telangana, and as Honorary Academic Advisor at Capital University of Kodarma District in Jharkhand. Dr. Singh is entitled to remuneration by way of sitting fees and reimbursement of expenses for participation in Board meetings, within the limits specified under the Companies Act, 2013 and the Listing Regulations, 2015.

His other current directorships include SNR Edatas Private Limited, Equipp Social Impact Technologies Limited, IRB Infrastructure Developers Limited, and Ajayan Consulting Private Limited.

Regulatory Compliance

The disclosures were made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in accordance with SEBI LODR Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated 30th January 2026. The Postal Ballot Notice has been uploaded on the company's website and the results, once announced, will also be displayed at the registered office. TANFAC Industries is a joint sector company with TIDCO and Anupam Rasayan India Ltd., with its registered office and factory located at 14, SIPCOT Industrial Complex, Cuddalore – 607 005, Tamil Nadu, India.

Historical Stock Returns for TANFAC Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+1.99%-4.84%-19.51%+3.08%+29.07%+1,649.46%

How might Dr. L. Ravichandran's four-decade operational expertise influence TANFAC Industries' R&D pipeline and new product commercialization strategy over his two-year tenure?

Could Dr. Ajay Kumar Singh's academic and consulting background, particularly his ties to ISB Hyderabad and corporate training experience, signal a shift in TANFAC's governance or strategic direction?

Given that TANFAC Industries is a joint sector company with TIDCO and Anupam Rasayan India Ltd., how might these new board appointments affect the company's alignment with its parent entities' broader business objectives?

Tanfac FY26 Revenue Rs 711 Cr; Fluorinated Plant Set for Q3 FY27

3 min read     Updated on 07 May 2026, 11:50 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Tanfac Industries achieved its highest-ever revenue of Rs 711 crore in FY26, with a PAT margin of 9.9%. The company is expanding its fluorinated product capacity with a Rs 495 crore investment in a new plant scheduled for Q3 FY27 commissioning. Recent long-term supply agreements and the successful commissioning of the Solar Grade DHF project have significantly bolstered the order book and revenue visibility.

powered bylight_fuzz_icon
39643852

*this image is generated using AI for illustrative purposes only.

Tanfac Industries has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported its highest-ever quarterly and full-year revenue from operations of Rs 193 crores and Rs 711 crores, respectively. The Board of Directors has recommended a final dividend of Rs. 4.50 per equity share for the financial year 2025-26, subject to shareholder approval.

Strategic Expansion and Capital Expenditure

In line with its long-term growth strategy, the company is progressing with a capital expenditure plan of approximately Rs. 495 crores to expand its downstream fluorinated product portfolio. The development of the 20,000 TPA fluorinated product plant is proceeding as scheduled and is expected to be commissioned by Q3 FY27.

The following table summarizes the key parameters of the announced investment:

Parameter: Details
Investment Amount: Rs. 495 crores
Facility Type: Fluorinated Product Plant
Capacity: 20,000 TPA
Expected Commencement: Q3 FY27

Business Wins and Operational Highlights

Over the last five months, Tanfac Industries secured three consecutive long-term supply arrangements for fluorinated products with leading global customers. These contracts aggregate to approximately Rs 3,612 crores over a period of 5-7 years, along with an additional agreement valued at around Rs 61 crores per annum for an indefinite duration.

The company also successfully commissioned both phases of its Solar Grade DHF project, with a total annual capacity of 20,000 metric tonnes, in June and October 2025 respectively. It has secured orders for Rs 1,068 crores to be executed over the next 3.5 years, strengthening the project's revenue visibility.

Financial Performance

For the financial year 2026, the company achieved a Gross Profit margin of 37.5% and an Operating EBITDA margin of 15.8%. The Net Profit margin stood at 9.9%. The Return on Equity (ROE) was reported at 34%, while the Return on Capital Employed (ROCE) was 65% for FY26.

Historical Stock Returns for TANFAC Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+1.99%-4.84%-19.51%+3.08%+29.07%+1,649.46%

How might the commissioning of the 20,000 TPA fluorinated product plant in Q3 FY27 impact Tanfac's ability to fulfill its ₹3,612 crore long-term supply agreements, and could capacity constraints emerge before then?

Given the margin compression seen in FY26 (EBITDA margin falling from 23.1% to 15.8%), will the ramp-up of higher-value fluorinated products and Solar Grade DHF be sufficient to restore margins to FY25 levels?

As Tanfac is currently India's sole supplier of Solar Grade DHF, how vulnerable is its first-mover advantage to potential new domestic entrants or cheaper Chinese imports in this segment?

More News on TANFAC Industries

1 Year Returns:+29.07%